FDA Approves Verkazia

FDA Approves Verkazia (cyclosporine ophthalmic emulsion) for the Treatment of Vernal Keratoconjunctivitis EMERYVILLE, Calif.–(BUSINESS WIRE) June 24, 2021 –Santen Inc.,

Chemmart Perindopril

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CHEMMART PERINDOPRIL tablets Contains the active ingredient

Primacor

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. Primacor Injection Milrinone Lactate CONSUMER MEDICINE INFORMATION

Brolene

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. BROLENE® (BRO-leen) propamidine isethionate Consumer Medicine Information

Hydroform

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. HYDROFORM CREAM 1% Hydrocortisone (microfine) 1% w/w

Glimepiride APOTEX

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. GLIMEPIRIDE APOTEX Glimepiride Consumer Medicine Information What

Olmesartan/Amlodipine APOTEX

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. OLMESARTAN/AMLODIPINE APOTEX Olmesartan medoxomil and amlodipine besilate

Bactroban Ointment

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. BACTROBAN® OINTMENT Mupirocin (2%w/w) Consumer Medicine Information

Zeklen

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ZEKLEN® Ezetimibe/Simvastatin Consumer Medicine Information What is

Contrave 8/90

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CONTRAVE®8/90 This medicine is subject to additional

Ceptolate

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CEPTOLATE mycophenolate mofetil Consumer Medicine Information What